Effect of Bezafibrate on Muscle Metabolism in Patients With Fatty Acid Oxidation Defects
Conditions
- Carnitine Palmitoyltransferase II Deficiency
- Very Long Chain Acyl Coa Dehydrogenase Deficiency
Interventions
- DRUG: Bezafibrate
- OTHER: Placebo
Sponsor
Rigshospitalet, Denmark
Collaborators